Acrivon 治療公司 - 資產負債表 (Quarterly)

Acrivon 治療公司
US ˙ NasdaqGM ˙ US0048901096

資產負債表 (Quarterly)

Acrivon 治療公司資產負債表反映公司在特定時間點的帳戶餘額。財務狀況表數據包括資產、流動資產、固定資產、不動產、廠房和設備(PPE)、存貨、無形資產、負債、流動負債、長期負債、融資租賃負債、普通股、保留盈利、庫存股和股東權益。

除以每股為單位的數字外,所有數字為1,000,000.00倍數。

2021
12-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
現金 100 84 32 30 27 38 30 36 25 46 43 40 39 42 35 41 34
改變 (%) -15.80 -61.75 -7.98 -6.88 38.51 -21.58 20.62 -31.68 86.96 -5.63 -8.29 -1.67 7.00 -15.49 17.21 -17.92
流動資產 100 87 79 132 124 153 144 130 112 182 189 182 151 138 130 120 99
改變 (%) -13.19 -9.74 67.91 -6.16 23.65 -5.73 -10.24 -13.53 62.61 3.63 -3.89 -16.68 -8.53 -5.82 -7.61 -17.62
資產 107 95 88 181 170 160 151 138 121 231 215 197 176 159 145 130 108
改變 (%) -10.87 -7.67 106.61 -6.09 -5.96 -5.60 -8.49 -12.83 91.32 -6.90 -8.43 -10.30 -10.07 -8.38 -10.72 -16.87
負債 8 9 11 11 10 11 13 17 13 15 18 20 16 16 17 17 12
改變 (%) 14.93 19.41 -0.55 -9.52 11.69 19.13 31.89 -26.53 15.83 22.48 11.30 -19.41 -2.59 7.40 3.02 -28.39
公平 99 86 77 170 160 149 138 121 108 216 197 177 160 143 129 113 96
改變 (%) -12.93 -10.52 121.68 -5.87 -7.03 -7.40 -12.27 -10.90 100.09 -8.87 -10.21 -9.27 -10.82 -10.09 -12.51 -15.11
負債和股本 107 95 88 181 170 160 151 138 121 231 215 197 176 159 145 130 108
改變 (%) -10.87 -7.67 106.61 -6.09 -5.96 -5.60 -8.49 -12.83 91.32 -6.90 -8.43 -10.30 -10.07 -8.38 -10.72 -16.87

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista